Related Experiment Video
Updated: Dec 26, 2025

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
Intestinal bile acids directly modulate the structure and function of C. difficile TcdB toxin
John Tam1, Simoun Icho1,2, Evelyn Utama1,2
1Molecular Medicine, Research Institute, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
Intestinal bile acids bind and neutralize the TcdB toxin, a key factor in Clostridioides difficile infections. This discovery offers a new strategy for developing antitoxins against C. difficile disease.
Area of Science:
- Microbiology
- Toxicology
- Gastroenterology
Background:
- Intestinal bile acids influence Clostridioides difficile (C. difficile) growth and germination.
- Toxin B (TcdB) is the primary virulence factor responsible for C. difficile disease.
Purpose of the Study:
- To investigate the direct role of intestinal bile acids in neutralizing TcdB toxin.
- To identify potential therapeutic strategies for C. difficile infections based on bile acid mechanisms.
Main Methods:
- Biochemical assays to assess bile acid binding and inhibition of TcdB.
- Structural analysis to understand the mechanism of TcdB neutralization.
- High-throughput screening to identify bile acid mimetics.
Main Results:
- Primary and secondary bile acids reversibly bind and inhibit TcdB activity.
- Bile acids induce a conformational change in TcdB, preventing cell receptor binding.
- A novel region of TcdB, the oligopeptide repeats, is crucial for bile acid interaction.
- Nonsteroidal small molecules mimicking bile acid action were identified.
Conclusions:
- Intestinal bile acids play a direct role in neutralizing TcdB toxin, impacting C. difficile pathogenesis.
- Bile acid-mediated TcdB inhibition provides a novel therapeutic avenue.
- The identified bile acid mimetics represent a new class of potential C. difficile antitoxins.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.

